Published in Virology on March 01, 1970
Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. Proc Natl Acad Sci U S A (1974) 5.54
DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus. J Virol (1978) 3.41
DNA of Epstein-Barr virus. I. Comparative studies of the DNA of Epstein-Barr virus from HR-1 and B95-8 cells: size, structure, and relatedness. J Virol (1975) 3.13
Replication of latent Epstein-Barr virus genomes in Raji cells. J Virol (1987) 2.98
Heterogeneity of Epstein-Barr virus. III. Comparison of a transforming and a nontransforming virus by partial denaturation mapping of their DNAs. J Virol (1978) 2.78
The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med (1996) 2.67
Linear association between cellular DNA and Epstein-Barr virus DNA in a human lymphoblastoid cell line. Proc Natl Acad Sci U S A (1973) 2.27
Organization of repeated regions within the Epstein-Barr virus DNA molecule. J Virol (1980) 2.12
DNA of Epstein-Barr virus. VI. Mapping of the internal tandem reiteration. J Virol (1979) 2.10
Episomal viral DNA in a Herpesvirus saimiri-transformed lymphoid cell line. J Virol (1977) 1.93
Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J Virol (1996) 1.92
Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine. Proc Natl Acad Sci U S A (1971) 1.78
Circular Epstein-Barr virus genomes of reduced size in a human lymphoid cell line of infectious mononucleosis origin. J Virol (1977) 1.77
Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood. J Virol (1975) 1.66
Latent DNA of Epstein-Barr virus: separation from high-molecular-weight cell DNA in a neutral glycerol gradient. Proc Natl Acad Sci U S A (1974) 1.62
Clustered repeat sequences in the genome of Epstein Barr virus. Nucleic Acids Res (1983) 1.53
Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man. Yale J Biol Med (1971) 1.38
Viral and cellular DNA synthesis in nuclei from human lymphocytes transformed by Epstein-Barr virus. Proc Natl Acad Sci U S A (1975) 1.34
Purification of the JS-3 isolate of Herpesvirus ovis (Bovid herpesvirus 4) and some properties of its DNA. J Virol (1979) 0.75
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (1985) 11.11
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J (1984) 10.28
Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature (1978) 9.25
EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (1970) 8.08
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A (1983) 6.81
Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol (1982) 5.49
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol (1977) 5.21
Molecular cloning of viral DNA from human genital warts. J Virol (1981) 4.50
Presence of EB virus nucleic acid homology in a "virus-free" line of Burkitt tumour cells. Nature (1970) 4.41
Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet (1982) 4.31
Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA. Int J Cancer (1982) 4.30
The nucleotide sequence and genome organization of human papilloma virus type 11. Virology (1986) 4.04
Partial characterization of viral DNA from human genital warts (Condylomata acuminata). Int J Cancer (1980) 4.03
Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines. Nat New Biol (1972) 3.84
Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med Microbiol Immunol (1987) 3.70
Structural relationship of Salmonella O and R antigens. Ann N Y Acad Sci (1966) 3.54
EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol (1973) 2.71
Condylomata acuminata and human genital cancer. Cancer Res (1976) 2.67
Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H. J Virol (1985) 2.56
Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc Natl Acad Sci U S A (1979) 2.55
Complete DNA sequence of lymphotropic papovavirus: prototype of a new species of the polyomavirus genus. Virology (1985) 2.53
Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology (1984) 2.49
DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res (1988) 2.39
Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. Int J Cancer (1983) 2.30
Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28
Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus. Virology (1986) 2.26
Lymphotropic papovaviruses isolated from African green monkey and human cells. Med Microbiol Immunol (1979) 2.23
Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells. J Virol (1984) 2.23
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology (1984) 2.13
Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet (1987) 2.13
Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. J Virol (1967) 2.07
Oncogenic Herpes viruses. Biochim Biophys Acta (1975) 2.01
The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification. J Virol (1990) 2.00
Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from Upper-volta. Int J Cancer (1981) 1.99
Attempts to detect virus-secific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus. Int J Cancer (1974) 1.98
Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol (1999) 1.94
NC37-R1 Epstein-Barr virus (EBV): a possible recombinant between intracellular NC37 viral DNA and superinfecting P3HR-1 EBV. Intervirology (1980) 1.92
Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitation. Virology (1979) 1.85
Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet (1986) 1.82
Human papilloma virus DNA: physical mapping and genetic heterogeneity. Proc Natl Acad Sci U S A (1976) 1.76
Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1. EMBO J (1992) 1.74
Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J Virol (1998) 1.72
Papillomaviruses in human cancer. Cancer (1987) 1.71
B-lymphotropic papovavirus and possibility of infections in humans. J Med Virol (1981) 1.68
Genomic localization, sequence analysis, and transcription of the putative human cytomegalovirus DNA polymerase gene. J Virol (1987) 1.67
Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology (1992) 1.64
Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frames. Virology (1994) 1.63
Genital papillomavirus infections. Prog Med Virol (1985) 1.58
Viruses in the etiology of human genital cancer. Prog Med Virol (1984) 1.54
A subset of herpes simplex virus replication genes induces DNA amplification within the host cell genome. J Virol (1989) 1.52
Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res (1994) 1.51
Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV. Int J Cancer (1978) 1.49
Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol (1985) 1.47
Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180. J Virol (1991) 1.42
Propagation of B-lymphotropic papovavirus (LPV) in human B-lymphoma cells and characterization of its DNA. Virology (1981) 1.37
Epstein-Barr virus-induced proteins. II. Analysis of surface polypeptides from EBV-producing and -superinfected cells by immunoprecipitation. Virology (1980) 1.34
Epstein-Barr virus-induced transformation of human leukocytes after cell fractionation. Int J Cancer (1975) 1.33
Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA. Int J Cancer (1992) 1.33
A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol (1992) 1.32
Presence of human papillomavirus in genital tumors. J Invest Dermatol (1984) 1.29
Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J Virol (1991) 1.27
Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res (1983) 1.25
Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Med Microbiol Immunol (1983) 1.25
Inhibition of initiator-induced SV40 gene amplification in SV40-transformed Chinese hamster cells by infection with a defective parvovirus. Int J Cancer (1983) 1.23
Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV. Int J Cancer (1980) 1.22
Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene (2001) 1.18
Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci U S A (1991) 1.17
Analysis of benign and malignant urogenital tumors for human papillomavirus infection by labelling cellular DNA. Med Microbiol Immunol (1986) 1.17
Localization of viral DNA-replication in sections of human warts by nucleic acid hybridization with complementary RNA of human papilloma virus Type 1. Arch Dermatol Res (1979) 1.16
Papillomavirus DNA in human tongue carcinomas. Int J Cancer (1985) 1.16
Epstein-Barr virus-induced proteins. III. Analysis of polypeptides from P3HR-1-EBV-superinfected NC37 cells by immunoprecipitation. Virology (1980) 1.15
EBV DNA in nonlymphoid cells of nasopharyngeal carcinomas and in a malignant lymphoma obtained after inoculation of EBV into cottontop marmosets. Cold Spring Harb Symp Quant Biol (1975) 1.14
Unusual HPV types in oral warts in association with HIV infection. J Oral Pathol (1988) 1.13
BK virus: I. Seroepidemiologic studies and serologic response to viral infection. Med Microbiol Immunol (1978) 1.12
Effect of herpes simplex virus on cultured Burkitt tumor cells and its failure to influence the Epstein-Barr virus carrier state. Cancer Res (1969) 1.11
Tumour promoter TPA enhances transformation of human leukocytes by Epstein-Barr virus. Nature (1979) 1.11
Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins. J Virol (1997) 1.10
Chromosomal changes of similar nature in seven established cell lines derived from the peripheral blood of patients with leukemia. J Natl Cancer Inst (1967) 1.10
Interactions of adenovirus type 12 with host cell chromosomes. Prog Exp Tumor Res (1973) 1.10
Papillomavirus infections and human genital cancer. Gynecol Oncol (1981) 1.10
Retinoic acid inhibition of Epstein-Barr virus induction. Nature (1979) 1.09
Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European Burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis. Int J Cancer (1976) 1.09
The effect of DNA methylation on gene regulation of human papillomaviruses. J Gen Virol (1993) 1.09
Adeno-associated viruses inhibit SV40 DNA amplification and replication of herpes simplex virus in SV40-transformed hamster cells. Virology (1988) 1.09
The role of viruses in human tumors. Adv Cancer Res (1980) 1.09
Epstein-Barr virus in human tumor cells. Int Rev Exp Pathol (1972) 1.08
Presence of human papillomavirus type-16 and type-18 DNA sequences and their expression in cervical cancers and cell lines from Japanese patients. Int J Cancer (1986) 1.07
Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J Virol (1997) 1.06
Molecular cloning of two new HPV types (HPV 37 and HPV 38) from a keratoacanthoma and a malignant melanoma. Int J Cancer (1986) 1.04
Selective killing of carcinogen-treated SV40-transformed Chinese hamster cells by a defective parvovirus. Virology (1984) 1.03
Mutants of adenovirus type 12 after adaptation to growth in tumor cell lines. II. Reproducible acquisition of additional sequences after adaptation to a human cervical cancer line. Int J Cancer (1981) 1.02
Characterization of a new human papillomavirus (HPV 41) from disseminated warts and detection of its DNA in some skin carcinomas. Int J Cancer (1988) 1.02